chr1-115651261-T-TC
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_138959.3(VANGL1):c.-137-11dup variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0149 in 661,980 control chromosomes in the GnomAD database, including 636 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.044 ( 465 hom., cov: 32)
Exomes 𝑓: 0.0064 ( 171 hom. )
Consequence
VANGL1
NM_138959.3 splice_polypyrimidine_tract, intron
NM_138959.3 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.40
Genes affected
VANGL1 (HGNC:15512): (VANGL planar cell polarity protein 1) This gene encodes a member of the tretraspanin family. The encoded protein may be involved in mediating intestinal trefoil factor induced wound healing in the intestinal mucosa. Mutations in this gene are associated with neural tube defects. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 1-115651261-T-TC is Benign according to our data. Variant chr1-115651261-T-TC is described in ClinVar as [Benign]. Clinvar id is 1301804.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.148 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VANGL1 | NM_138959.3 | c.-137-11dup | splice_polypyrimidine_tract_variant, intron_variant | ENST00000355485.7 | |||
VANGL1 | NM_001172411.2 | c.-137-11dup | splice_polypyrimidine_tract_variant, intron_variant | ||||
VANGL1 | NM_001172412.2 | c.-137-11dup | splice_polypyrimidine_tract_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VANGL1 | ENST00000355485.7 | c.-137-11dup | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_138959.3 | P3 | |||
VANGL1 | ENST00000310260.7 | c.-137-11dup | splice_polypyrimidine_tract_variant, intron_variant | 1 | P3 | ||||
VANGL1 | ENST00000369510.8 | c.-137-11dup | splice_polypyrimidine_tract_variant, intron_variant | 1 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0434 AC: 6566AN: 151228Hom.: 460 Cov.: 32
GnomAD3 genomes
AF:
AC:
6566
AN:
151228
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00644 AC: 3288AN: 510634Hom.: 171 Cov.: 6 AF XY: 0.00584 AC XY: 1605AN XY: 274918
GnomAD4 exome
AF:
AC:
3288
AN:
510634
Hom.:
Cov.:
6
AF XY:
AC XY:
1605
AN XY:
274918
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0436 AC: 6594AN: 151346Hom.: 465 Cov.: 32 AF XY: 0.0420 AC XY: 3105AN XY: 73976
GnomAD4 genome
AF:
AC:
6594
AN:
151346
Hom.:
Cov.:
32
AF XY:
AC XY:
3105
AN XY:
73976
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital | Dec 30, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at